Modulation of mutagen-induced biological effects by inhibitors of DNA repair.
D000477:Alkylating Agents / Q000633:toxicity; D001549:Benzamides / Q000633:toxicity; D002869:Chromosome Aberrations; D003561:Cytarabine / Q000494:pharmacology; D004247:DNA / Q000528:radiation effects; D004257:DNA Polymerase II / Q000037:antagonists & inhibitors; D004260:DNA Repair / Q000187:drug effects; D004347:Drug Interactions; D004357:Drug Synergism; D006801:Humans; D008214:Lymphocytes / Q000166:cytology / Q000187:drug effects / Q000528:radiation effects; D009153:Mutagens / Q000494:pharmacology*; D009154:Mutation; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D012854:Sister Chromatid Exchange / Q000187:drug effects
D000477:Alkylating Agents; D001549:Benzamides; D009153:Mutagens; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D003561:Cytarabine; C025160:3-aminobenzamide; D004247:DNA; D004257:DNA Polymerase II